Boardroom Alpha
Boardroom Alpha
AMSF · Current Report (Form 8-K) · Filed November 3, 2025

Amerisafe Inc — Current Report (Form 8-K)

Form
8-K
Filed
November 3, 2025
Period
Oct 31, 2025
Ticker
AMSF
Accession
0001193125-25-262638
Boardroom Alpha · Filing insights

Amerisafe CFO Anastasios Omiridis resigns effective November 30, 2025; CEO G. Janelle Frost will serve as interim CFO during the search.

About Amerisafe Inc
Market cap
$487M
1Y TSR
−34.8%
3Y TSR
−12.2%
Board grade
C-
Sector
Financial Services
CEO
G Janelle Frost
Last annual meeting: Jun 10, 2026 · View full Amerisafe Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 31, 2025

 

 

AMERISAFE, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Texas   001-12251   75-2069407

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

2301 Highway 190 West

DeRidder, Louisiana 70634

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (337) 463-9052

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered or to be registered pursuant to Section 12(b) of the Act.

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   AMSF   Nasdaq Stock Market LLC

 

 
 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 31, 2025, Anastasios Omiridis notified AMERISAFE, Inc. (the “Company”) of his intention to resign from his position as Executive Vice President and Chief Financial Officer of the Company, effective November 30, 2025, to pursue another opportunity. Mr. Omiridis’ departure is not due to a conflict or disagreement with the Company or the Company’s operations, policies or procedures.

Mr. Omiridis will continue to serve in his role as Executive Vice President and Chief Financial Officer until November 30, 2025, the effective time of his resignation. The Company plans to commence an executive search for a new Chief Financial Officer. Following Mr. Omiridis’ departure, the Company’s President and Chief Executive Officer, G. Janelle Frost, will assume the duties of principal financial officer and principal accounting officer while the Company conducts a search for a new Chief Financial Officer. Ms. Frost’s biographical information and compensation arrangements are set forth in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 30, 2025, and is incorporated by reference herein.

 

Item 7.01.

Regulation FD Disclosure.

On November 3, 2025, the Company issued a press release announcing Mr. Omiridis’ resignation. A copy of the Company’s press release, dated November 3, 2025, is furnished as Exhibit 99.1 to this current report on Form 8-K.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
Number

  

Description

99.1    Press release, dated November 3, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL Document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMERISAFE, INC.
By:  

/s/ Kathryn H. Shirley

  Kathryn H. Shirley,
  Executive Vice President, Chief
  Administrative Officer and Secretary

Date: November 3, 2025

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Amerisafe Inc (AMSF)

Reference

Frequently asked questions

When did Amerisafe Inc file this 8-K?
Amerisafe Inc (AMSF) filed this Current Report (Form 8-K) with the SEC on November 3, 2025. The accession number assigned by EDGAR is 0001193125-25-262638.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Amerisafe CFO Anastasios Omiridis resigns effective November 30, 2025; CEO G. Janelle Frost will serve as interim CFO during the search. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Amerisafe Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Amerisafe Inc has filed under CIK 1018979, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer